Literature DB >> 3274493

Disappearance of mesangial IgA deposits from the kidneys of two donors after transplantation.

X Cuevas1, J Lloveras, M Mir, J Aubia, J Masramon.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3274493

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  11 in total

1.  A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy.

Authors:  Annamaria Milillo; Francesca La Carpia; Stefano Costanzi; Vanessa D'Urbano; Maurizio Martini; Paola Lanuti; Gisella Vischini; Luigi M Larocca; Marco Marchisio; Sebastiano Miscia; Antonio Amoroso; Fiorella Gurrieri; Eugenio Sangiorgi
Journal:  Eur J Hum Genet       Date:  2015-03-18       Impact factor: 4.246

Review 2.  Treatment of IgA nephropathy and Henoch-Schönlein nephritis.

Authors:  Jürgen Floege; John Feehally
Journal:  Nat Rev Nephrol       Date:  2013-04-02       Impact factor: 28.314

3.  Allogeneic bone marrow transplantation appears to ameliorate IgA nephropathy in a patient with X-linked thrombocytopenia.

Authors:  Akihiro Hoshino; Masaki Shimizu; Hiroyoshi Matsukura; Hisano Sakaki-Nakatsubo; Keiko Nomura; Toshio Miyawaki; Hirokazu Kanegane
Journal:  J Clin Immunol       Date:  2013-11-12       Impact factor: 8.317

Review 4.  Immunopathogenesis of IgAN.

Authors:  Jonathan Barratt; Alice C Smith; Karen Molyneux; John Feehally
Journal:  Semin Immunopathol       Date:  2007-09-13       Impact factor: 9.623

Review 5.  Pathological role of tonsillar B cells in IgA nephropathy.

Authors:  Yusuke Suzuki; Hitoshi Suzuki; Junichiro Nakata; Daisuke Sato; Tadahiro Kajiyama; Tomonari Watanabe; Yasuhiko Tomino
Journal:  Clin Dev Immunol       Date:  2011-07-18

6.  Different pathological roles of toll-like receptor 9 on mucosal B cells and dendritic cells in murine IgA nephropathy.

Authors:  Tadahiro Kajiyama; Yusuke Suzuki; Masao Kihara; Hitoshi Suzuki; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  Clin Dev Immunol       Date:  2011-06-30

7.  Synergistic effect of mesangial cell-induced CXCL1 and TGF-β1 in promoting podocyte loss in IgA nephropathy.

Authors:  Li Zhu; Qingxian Zhang; Sufang Shi; Lijun Liu; Jicheng Lv; Hong Zhang
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

8.  Changes in nephritogenic serum galactose-deficient IgA1 in IgA nephropathy following tonsillectomy and steroid therapy.

Authors:  Junichiro Nakata; Yusuke Suzuki; Hitoshi Suzuki; Daisuke Sato; Tatsuya Kano; Hiroyuki Yanagawa; Keiichi Matsuzaki; Satoshi Horikoshi; Jan Novak; Yasuhiko Tomino
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

9.  Maternally inherited diabetes and deafness complicated by mesangial galactose-deficient IgA1 deposits: a case report.

Authors:  Keiji Sugai; Hiroyuki Ueda; Keita Morimoto; Mai Tanaka; Daisuke Takahashi; Akio Nakashima; Junichiro Kato; Hiroshi Takahashi; Yutaka Yamaguchi; Tetsuya Kawamura; Kazushige Hanaoka; Yoichi Miyazaki; Takashi Yokoo
Journal:  BMC Nephrol       Date:  2018-12-10       Impact factor: 2.388

10.  Elevated hsa-miR-590-3p expression down-regulates HMGB2 expression and contributes to the severity of IgA nephropathy.

Authors:  Yaling Zhai; Yuanyuan Qi; Xiaoqing Long; Yanna Dou; Dong Liu; Genyang Cheng; Jing Xiao; Zhangsuo Liu; Zhanzheng Zhao
Journal:  J Cell Mol Med       Date:  2019-09-26       Impact factor: 5.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.